CPC A61B 18/1492 (2013.01) [A61B 18/04 (2013.01); A61B 18/1477 (2013.01); A61B 18/1485 (2013.01); A61B 18/18 (2013.01); A61B 18/1815 (2013.01); A61B 18/24 (2013.01); A61F 7/12 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/00083 (2013.01); A61B 2018/00267 (2013.01); A61B 2018/00517 (2013.01); A61B 2018/00523 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/143 (2013.01); A61B 2018/183 (2013.01); A61B 2018/1861 (2013.01)] | 20 Claims |
1. A method to modulate function of a patient's bladder, the method comprising:
positioning an elongate energy delivery element within non-superficial target tissue of a trigone region of the bladder so that the elongate energy delivery element is generally parallel to a mucosal surface of the bladder; and
delivering ablation energy from the elongate energy delivery element into the non-superficial target tissue, thereby ablating the non-superficial target tissue, without ablating the mucosal surface.
|